Advances in Point-of-Care Cell Engineering—What Are You Feeding Your CAR T Cells?
In this webinar, Dr. Julian J. Lum discusses key factors to consider when choosing metabolic assays and how they can be used to assess cell function. Additionally, he discusses the metabolic characteristics of different commercially available cell culture media formulations as well as the importance of assessing the array of media products and their impact on metabolism.
This webinar is part of the “Translational T Cell Talks: Scaling for the Future” event hosted in collaboration with Scientist.com on June 11, 2024. View the rest of the talks and read the Q&A transcripts.
Over the past five years, significant progress has propelled the manufacturing of clinical cell therapies toward the feasibility of point-of-care production within academic centers. The transition to a decentralized system has been made possible by advancements in small, adaptable, closed manufacturing devices. Additionally, the range of ancillary reagents essential for large-scale production has expanded, with numerous GMP-grade commercial products now available on the market.
In this webinar, Dr. Julian J. Lum discusses key factors to consider when choosing metabolic assays and how they can be used to assess cell function. Additionally, he discusses the metabolic characteristics of different commercially available cell culture media formulations as well as the importance of assessing the array of media products and their impact on metabolism.
This webinar is part of the “Translational T Cell Talks: Scaling for the Future” event hosted in collaboration with Scientist.com on June 11, 2024. View the rest of the talks and read the Q&A transcripts.
In this webinar, Dr. Julian J. Lum discusses key factors to consider when choosing metabolic assays and how they can be used to assess cell function. Additionally, he discusses the metabolic characteristics of different commercially available cell culture media formulations as well as the importance of assessing the array of media products and their impact on metabolism.
This webinar is part of the “Translational T Cell Talks: Scaling for the Future” event hosted in collaboration with Scientist.com on June 11, 2024. View the rest of the talks and read the Q&A transcripts.
Publish Date:
August 27, 2024
Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
By submitting this form, you are providing your consent to STEMCELL Technologies Canada Inc. and its subsidiaries and affiliates (“STEMCELL”) to collect and use your information, and send you newsletters and emails in accordance with our privacy policy. Please contact us with any questions that you may have. You can unsubscribe or change your email preferences at any time.
Related Multimedia
-
Accelerating T Cell Therapy Research
Publish Date: October 29, 2021 -
How to Optimize Your T Cell Therapy Workflow—Without the Use of Serum or Feeder Cells
Publish Date: August 27, 2024 -
Roundtable: Improving Collaboration Between Industry and Academia in the Field of CAR T Cell Therapy
Publish Date: August 27, 2024
Explore Our Products
-
StemSpan™ T Cell Generation Kit
Complete kit for expansion and differentiation of human CD34+ hematopoietic progenitor cells to T cells -
For expansion and differentiation of hPSCs to T cells -
cGMP, serum-free, and xeno-free medium for the expansion of human T cells
